5-Methyl-3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazole, 250mg

2-Methoxybutan-1-ol, 98%, 1g

(3R,4R)-3-(BOC-AMINO)-4-METHYLPIPERIDINE, 95.0%, 250mg

4-BROMO-2-FLUOROPYRIDINE-3-CARBOXYLIC ACID, 95.0%, 1g

2-methyl-1-(thiophene-2-carbonyl)piperazine, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-2-cyclopentylacetic acid, 97%, 5g

8-Bromo-6-methoxy-tetralin-1-one, 98%, 100mg

(2-Bromo-6-fluoro-3-methylsulfanylphenyl)methanol, 95%, 1g

tert-Butyl N-[(3R,5R)-5-Methylpyrrolidin-3-yl]carbamate, 97%, 1g

Solution d'hydroxyde de sodium, min 32 %, ultra pure, 30 l, emballage plastique.

2-Difluoromethoxy-5-methyl-phenylamine, 250mg

(4-((4-Cyanobenzyl)oxy)phenyl)boronic acid, 98+%, 100mg

2-Acetoxy-4'-phenoxybenzophenone, 90.0%, 1g